Global Real World Adelphi Real World has extensive international reach across Europe, USA, Asia, and Latin America, presenting an opportunity to upsell cross-border real-world evidence programs and global market access insights to multinational clients.

Lifecycle Evidence Their capability spans the complete lifecycle of a compound, with DSPs and bespoke non-interventional studies, positioning them to win additional projects as products move from development through launch and post-market monitoring.

Diverse Stakeholders Data generation touches physicians, patients, caregivers, and payers, enabling tailored insights for Health Outcomes, Medical Affairs, Market Access and Commercial teams, which can be packaged as multi-stakeholder evidence bundles for pharma clients.

Data & Tech Advanced tech stack including SQL, Python, Google Cloud and data-driven analytics supports scalable real-world evidence, suggesting opportunities to offer enhanced analytics, dashboards, and integrated data solutions to current and prospective customers.

Scale & Position Revenue in the mid six-figures to low seven-figures range with 201-500 employees signals scalable growth potential; target mid-market to upper-portfolio pharmaceutical clients seeking cost-effective, globally informed real-world insights.